MediScreenAI
Clinical Decision Support in Under 2 Minutes

By HeAIth - Doctors decide, AI assists

Pre-collect symptoms, generate intelligent questionnaires, deliver diagnostic support - transform 15-minute consultations into 2-minute reviews.

Join Our Advisory Board Request a Demo
Built for NHS & Private Practices
UK GDPR Compliant
MHRA Regulatory Pathway
NHS DSPT Standards

MediScreenAI: Early Diagnostic Intelligence

HeAIth's flagship product - AI decision support at the start of your diagnostic journey

The Challenge

Early diagnosis is where errors happen:

  • Assessment overwhelm with complex cases
  • Time pressure in consultations
  • Cognitive overload managing differentials
  • Anchoring bias risks
  • Investigation prioritisation challenges

Result: Delayed critical diagnoses, inefficient pathways.

The MediScreenAI Approach

Early diagnostic support, clinician-designed:

  • Starts at initial assessment
  • Analyses symptoms and findings
  • Suggests differential diagnoses
  • Recommends investigations
  • Flags critical conditions
  • Built with practicing doctors

Supports clinical judgment, does not replace it.

Early Assessment Support

Analyses symptoms, history, and observations at first contact to support comprehensive initial assessment.

First Point of Contact

Precision Symptom Clarity

Transforms vague patient descriptions into clinically actionable data. "Sometimes" becomes "3-4 times a week, mostly in the morning and afternoon" - giving doctors the specificity needed for accurate assessment.

Clinical Precision

SNOMED CT Clinical Communication

Communicates with healthcare professionals using SNOMED CT (Systematized Nomenclature of Medicine - Clinical Terms), ensuring standardised, interoperable clinical terminology across NHS and private systems.

NHS Standards

Building with Clinicians

Recruiting practising doctors to guide development. Join our advisory board to shape MediScreenAI for real clinical workflows.

Doctor-Led Development

Differential Diagnosis Aid

Evidence-based differentials and investigation recommendations at initial assessment, reducing cognitive load in busy clinics.

Clinical Decision Support

Our Journey to Market

1

MediScreenAI MVP Established

Q3 2025

  • Diagnostic engine developed
  • Algorithm training completed
  • Platform architecture established
  • Proof of concept validated
2

Clinical Advisory Board Formation

Q4 2025 - Current Phase

  • Recruiting 3-5 founding medical advisors
  • Establishing advisory board governance
  • Setting strategic direction
  • Building industry credibility
Express Your Interest →
3

Initial Product Refinement

Q1 2026 (3 months)

  • Algorithm refinement from clinical feedback
  • UI/UX optimisation for workflows
  • Regulatory: ISO 13485 QMS, Clinical Safety Officer, DCB0129 compliance
  • Data protection: DPIA, ICO registration, UK GDPR
  • Investor presentations preparation
4

Seed Funding Round

Q1-Q2 2026 (6 months)

  • Target: £500k-700k for regulatory pathway
  • Allocation: 45% regulatory & compliance, 35% product development, 15% clinical team, 5% operations
  • Investor pitches with regulatory roadmap
  • Strategic investor engagement
  • Due diligence and negotiations
5

Clinical Validation & Regulatory Approval

Q2 2026 - Q1 2027 (12 months)

  • Q2 2026: MHRA UKCA submission (Class IIb)
  • Multi-site clinical validation with NHS trusts
  • NHS DTAC completion (Cyber Essentials, FHIR)
  • UK Approved Body conformity assessment
  • Clinical Safety Case Report (DCB0129)
  • Q4 2026-Q1 2027: MHRA review process
6

UK Market Launch

Q2-Q4 2027 (9 months)

  • Q2-Q3 2027: NHS pilot (2-3 trusts)
  • Post-market surveillance activation
  • Real-world validation and refinement
  • Q4 2027: General UK availability
  • Scale to 50-100 practices Year 1
7

Product Refinement & International Expansion

2028+ (Ongoing)

  • Cost optimisation: Reduce costs, maintain accuracy
  • Accuracy: Algorithm improvements from real-world data
  • International: Regulatory analysis for EU, US, other markets
  • Multi-country scalability and localisation

Impact That Matters

For Patients

Earlier Recognition, Faster Care

Improved initial assessments identify serious conditions earlier and ensure appropriate investigations from first consultation.

Better first impressions matter

For Clinicians

Confidence at First Contact

Built with doctors who understand assessment pressure. AI support when you need it most - at diagnostic journey start.

Clinical expertise, amplified

For Healthcare Systems

More Efficient Diagnostic Pathways

Better assessments mean fewer unnecessary tests, appropriate first-line investigations, earlier urgent case identification.

Right investigations, first time

Doctors Decide, AI Assists

Clinician-Led Development

Recruiting doctors to drive product decisions - your expertise shapes this tool

Start of Diagnostic Process

Designed for initial assessment, not final diagnosis - supporting judgment where it matters

Real Clinical Workflows

Built for time-pressured A&E and GP reality - not idealised scenarios

Evidence-Based Suggestions

Every recommendation backed by clinical evidence, clearly explained

We are building for doctors with doctors - because we understand that initial assessment is where clinical judgment matters most, and where support is needed most. Join us to make this vision a reality.

Join Our Advisory Board

Help us build a tool where doctors decide, AI assists - we need your expertise to make this vision a reality

Drive Clinical Design

This will be genuine doctor-led development, not token involvement. Your clinical expertise will directly shape features, workflow, and how the tool supports initial assessments.

Founding Advisor Equity

As a founding advisor, you receive equity compensation while helping to build a tool that addresses real clinical needs.

Shape Early Diagnostic Support

Help us build a tool that supports clinicians at the critical start of the diagnostic process - drawing on your frontline experience.

The Ideal Advisor

We are seeking healthcare professionals who understand clinical challenges:

  • Clinical practice, healthcare leadership, or academic background (MD, MBBS, NP, PA, healthcare administrators, or equivalent)
  • Frontline experience with diagnostic decision-making
  • Understanding of early assessment challenges and pressures
  • Interest in clinical decision support tools
  • 2-4 hours monthly availability for product input
  • Commitment to improving diagnostic workflows

Particularly Valuable Specialties:

General Practice / Primary Care Emergency Medicine / A&E Acute & Internal Medicine Urgent Care NHS Digital Health Clinical Governance

What We Offer

As a founding clinical advisor, you will have:

  • Real influence: Direct input on clinical features and workflow design
  • Equity compensation
  • Early access: Use the platform as it develops
  • Regular engagement: Quarterly advisory meetings (virtual or in-person)
  • Collaborative development: Work directly with the founding team
  • Founding recognition: Acknowledged as a founding clinical advisor
  • Clinical validation: Potential involvement in pilot studies

Time Commitment: 2-4 hours/month

Term: 2 years (renewable)

Join Us

Only 3-5 founding advisor positions available. Actively practising clinicians preferred.

Request a MediScreenAI Demo

Experience MediScreenAI

See how MediScreenAI, our doctor-built clinical decision support platform, transforms information gathering at the start of your diagnostic process. Request a personalised demo.

What You'll See:

  • How MediScreenAI supports initial patient assessment
  • AI-powered questionnaires (8-15 questions vs 30-50 traditional)
  • Differential diagnosis suggestions based on presenting complaints
  • Doctor review workflow - see cases in under 2 minutes
  • UK-based clinical scenarios and case studies
  • Integration with NHS systems and private EHR platforms
  • UK GDPR and NHS DSPT compliance approach
  • MHRA regulatory pathway and clinical safety standards

Who Should Apply:

  • NHS trusts and foundation trusts
  • Private hospitals and healthcare groups
  • GP practices and primary care networks
  • Urgent care and emergency departments
  • Diagnostic centres and pathology labs

Product: MediScreenAI by HeAIth

Regulatory Status: MHRA submission planned Q2-Q3 2026

UK Launch: Q3 2026 (subject to funding and regulatory approval)

Limited Demo Slots Available

Latest News & Updates

Stay informed about our progress and insights on AI in healthcare

View All News →
IMPORTANT REGULATORY NOTICE

MediScreenAI is an investigational clinical decision support software developed by HeAIth and is currently in development. This product has NOT been approved by the MHRA, FDA, or any regulatory authority. It is not available for clinical use. Information on this website is for healthcare professionals, advisors, and investors only. Learn more →